Related Experiment Video
Updated: Aug 13, 2026
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Idiopathic thromboembolism associated with triphasic oral contraceptives
L J Miwa1, A L Edmunds, M S Shaefer
1Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha.
DICP : the Annals of Pharmacotherapy
|October 1, 1989
Summary
Triphasic oral contraceptives, designed to mimic natural hormonal fluctuations, have been linked to idiopathic thromboembolism. This study investigates the potential risks associated with these widely used reversible contraceptive methods.
Area of Science:
- Reproductive Health
- Pharmacology
- Thrombosis Research
Background:
- Oral contraceptives (OCs) are leading reversible contraception methods.
- Thromboembolic disease is a known risk associated with OCs.
- Higher estrogen doses in OCs correlate with increased thrombotic event risk.
Observation:
- Two cases of idiopathic thromboembolism linked to triphasic oral contraceptive use are presented.
- Triphasic OCs administer hormones mimicking menstrual cycle fluctuations.
- Prescribers may incorrectly assume triphasic OCs have lower adverse event rates.
Findings:
- The study highlights potential thromboembolic risks with triphasic OCs.
- Idiopathic thromboembolism occurred despite the triphasic formulation.
- Pathogenic mechanisms for OC-induced thromboembolism are discussed.
Implications:
- Further research is needed to clarify triphasic OC safety profiles.
- Clinicians should consider thromboembolic risk in all OC users.
- Patient counseling regarding OC risks must be comprehensive.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...